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NMR structureWe have determined the solution NMR structure of the intermembrane space domain (IMSD) of the
human mitochondrial ATPase associated with various activities (AAA) protease known as AFG3-like
protein 2 (AFG3L2). Our structural analysis and molecular dynamics results indicate that the IMSD is
peripherally bound to the membrane surface. This is a modiﬁcation to the location of the six IMSDs
in a model of the full length yeast hexaoligomeric homolog of AFG3L2 determined at low resolution
by electron cryomicroscopy [1]. The predicted protein–protein interaction surface, located on the
side furthest from the membrane, may mediate binding to substrates as well as prohibitins.
 2013 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Here we report the solution NMR structure of the intermem-
brane space domain (IMSD, residues) of humanmitochondrial ATP-
ase associated with various activities (AAA) protease AFG3-like
protein 2 (AFG3L2). In humans, AFG3L2 forms homo- or hetero-
oligomeric complexes with paraplegin (49% identical) in the mito-
chondrial inner membrane (IM). They are namedm-AAA proteases,
meaning that their catalytic domains are located in the mitochon-
drial matrix. The catalytic domains of both AFG3L2 and paraplegin
are made up of two subunits, the ATPase associated AAA domain
and the metallopeptidase domain (PD) responsible for substrate
proteolysis. A single chain of AFG3L2 or paraplegin has two trans-
membrane (TM) helices, so that the topology in the IM results in
the short N-terminus and large catalytic domain on the matrix side
and a small 70-residue IMSD on the lumen side. Established and
putative functions for m-AAA proteases have been extensively
characterized and several recent reviews are available [2–4].
Although the crucial functions of m-AAA proteases are proteolyticprocessing and degradation of both non-membrane and mem-
brane-embedded substrates, the role of IMSDs remains to be
determined.
AFG3L2 and paraplegin have mammalian, plant, and fungal
homologs, including yeast Yta10 and Yta12 (59% identical to
AFG3L2) in addition to the well-studied bacterial homolog, FtsH
(ﬁlamentous temperature sensitive H, 45% sequence identity),
which forms only homo-oligomers, and is essential for survival in
Escherichia coli. The IMSD of AFG3L2 belongs to a conserved protein
family (Pfam), Pfam PF06480.
Prior to the NMR structure reported here, no atomic resolution
information was available for domains in this diverse Pfam. How-
ever, the overall architecture of a m-AAA protease was recently
determined in a 12 Å-resolution cryo-electron tomography (CET)
map of yeast Yta10/Yta12 hetero-oligomer solubilized in a deter-
gent micelle [1]. The authors observed symmetrical hexamers that
rely on residues in PD for oligomerization. In their model, the six
IMSDs splayed-out in a hexagon around 12 clustered TM helices
and have no contact with IMSDs on other subunits [1]. Prediction
of the IM position based on the location of the TM helices resulted
in the IMSDs being half buried in the membrane. Our results, how-
ever, are inconsistent with this aspect of the model, rather, our
data suggests that this domain has only peripheral contacts with
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consistent with our structural data and molecular dynamics (MD)
simulations.
2. Materials and methods
2.1. Cloning, expression and puriﬁcation
The selected IMSD fragment of the afg3l2 gene was cloned into a
pET15 expression vector (NESG Clone ID HR6741A-15.1) as de-
scribed elsewhere [5,6]. The IMSD, residues 164–251 of AFG3L2,
included 11 non-native N-terminal residues (MGHHHHHHSHM).
Expression and puriﬁcation were conducted following standard
protocols of the Northeast Structural Genomics Consortium (NESG)
to prepare [U-13C, 15N]- and U-15N, 5% biosynthetically-directed
13C (NC5) samples [5,6] and details can be found in Supplemental
Procedures. The ﬁnal NMR samples were 0.7–1.0 mM in the NMR
buffer: 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM dithiothre-
itol, and 0.02% NaN3 at pH 6.5. The protein was monomeric under
the conditions used in the NMR experiments based on analytical
static light scattering in-line with gel ﬁltration chromatography
and rotational correlation time estimates from 15N relaxation data
(sc 7.1 ± 0.5 ns, Fig. S1).
2.2. NMR and structure determination
NMR data were collected at 298 K on NC and NC5 samples of
300 ll in 5 mm Shigemi NMR tubes on 600 MHz Varian Inova
spectrometer with a 5-mm HCN cold probe and 850 MHz Bruker
Avance III spectrometer equipped with a conventional 5-mm
HCN probe. A description of NMR experiments and methods for
structure determination and reﬁnement can be found in Supple-
mental Procedures. The assigned 1H–15N HSQC spectrum is pro-
vided as Fig. S2. Chemical shifts, NOESY peak lists, and raw FIDS
were deposited in the BioMagResBank with ID 18156). The ﬁnal
ensemble of 20 models and NMR resonance assignments were
deposited to the Protein Data Bank with ID 2LNA.
2.3. MD simulations
MD studies of the lowest energy structure from the NMR
ensemble (residues 16–95) with a 1-palmitoyl-2-oleo-
ylphosphatidylcholine (POPC) membrane were performed using
NAMD version 2.9 [7] with the CHARMM27 [8] force ﬁeld. The Vi-
sual Molecular Dynamics software, VMD version 1.8.7 [9], was
used for simulation setup and MD trajectory analysis. A pre-equil-
ibrated POPC bilayer with an 80 Å2 surface was generated with the
VMD membrane builder plugin. The IMSD was positioned >8 Å
above the membrane and the system was solvated into a water
box and neutralized with NaCl. Equilibration and simulations were
performed similar to those reported in the KcsA tutorial for VMD
and NAMD [10] and is described in detail in the Supplemental
Procedures.
3. Results
3.1. Solution NMR structure
The human AFG3L2 IMSD features an uncommon mixed a + b
fold comprised of two a-helices (a1, 20–30; a2, 67–81) and a
ﬁve-stranded b-sheet (b1, 16–17; b2, 33–39; b3, 43–48; b4, 60–
63; b5, 91–93;) arranged in a babbbab topology (Fig. 1A–C). The
ﬁrst helix (a1) has a break at Tyr27 resulting in a bend in the helix.
The b-sheet has an up–up–down–up–up topology with the order
b1–b4–b3–b2–b5 and packs against the two helices to form acompact structure, whereas a poorly-deﬁned loop is located be-
tween b3 and b4 (loop 3–4; Thr49-Gln58). Structural statistics
for the NMR ensemble are presented in Supplemental Table S1.
3.2. Homologs have the same predicted secondary structure
IMSDs of human paraplegin, yeast Yta10 and Yta12, share 36%,
40%, and 43% sequence identity with that of human AFG3L2. How-
ever, these 85-residue domains were all predicted to have the
same order of secondary structural elements by PSIPRED 3.0 [11]
(Fig. 1D). The prediction for the human AFG3L2 IMSD was in good
agreement with the NMR structure with the exception that the ﬁrst
short b-strand was slightly shifted from the PSIPRED prediction
(Fig. 1D). Similarly, the 70-residue E. coli FtsH periplasmic do-
main had an equivalent secondary structure prediction although
it is 14 residues shorter (Fig. 1D). This result suggests that the
IMSD structure will be conserved within Pfam PF06480, including
bacterial homologs.
3.3. Structural alignment comparison and protein–protein interaction
prediction
Structural alignment analysis of AFG3L2 IMSD by Dali [12]
found no protein structures with RMSD <2.5 Å or sequences with
>20% identity. Dali identiﬁed the 60S eukaryotic ribosome subunit
protein L38 (PDB ID 3U5E:k and 4A18:p, Z-scores 4–5) as a similar
topology protein. L38 is part of a large complex of ribosomal pro-
teins. According to predictions of protein–protein interactions by
PredUS [13], residues near a1 (Asn 26) and part of the a2-loop-
b5 (Gly82-Glu86, with the highest score for Gly85) are likely to
interact with other proteins (Fig. 3C and D). The prediction is pri-
marily due to structural alignment with the N-terminal domain
of the molecular chaperone heat shock protein Hsp90 (Fig. S4). This
domain contains an ATP binding site and binds co-chaperones (re-
viewed in [14]). In human cells, Hsp90 binds to more than 10
known co-chaperones that together with Hsp90 regulate the sta-
bility and activation of other proteins, many of which are involved
in cellular signaling pathways. For example, the co-chaperone
Cdc37 regulates Hsp90 interactions with kinases and the stability
of the respective kinases determined the extent of association with
Hsp90, with unstable kinases having increased afﬁnity [15]. Taken
together, the structural alignment results indicate a role in the
assembly of protein–protein complexes that could regulate sub-
strate recognition.
3.4. Membrane interaction surface
In AFG3L2, the interaction of the IMSD with the membrane is
governed, in part, by the tethering to the TM helices at its N- and
C-termini. Analysis of the IMSD surface electrostatic surface poten-
tial [16] revealed a patch of basic and hydrophobic residues at one
end of the protein that constitutes a putative membrane interac-
tion surface (Fig. 2A–D). It is primarily made up of loops between
secondary structural elements, including loop 2–3 and loop 3–4
(Fig. 2A–D). Solvent exposed hydrophobic residues, as well as basic
residues from this surface are shown in Fig. 2A and B. It is well
known that Trp and Tyr residues have a preferred localization at
membrane interfaces and that Arg and Lys residues can interact
with phospholipid headgroups.
ConSurf [17] analysis revealed that conserved residues across
the eukaryotic homologs are located on one side and that the puta-
tive membrane binding surface has few conserved residues. The
conserved surface patch has an acidic surface resulting primarily
from residues Glu71 and Glu75 (Fig. 2C and E), but the function
of this patch is unknown. On the putative membrane-binding
Fig. 1. Structure and topology of AFG3L2 IMSD. (A) Cartoon representation of the lowest energy NMR structure, a-helices and b-strands are shown in blue and orange, and
loops are colored green or grey, if they were not ordered residues. (B) Superposition of the ﬁnal ensemble of 20 models (residues 14–96). (C) Domain topology obtained using
PDBSum [35]. (D) IMSDs from human AFG3L2 and paraplegin, yeast Yta10 and Yta12, and E. coli FtsH. Alignment of human and yeast sequences was performed with Clustal W
2.0 [36] and the consensus is reported. FtsH alignment is based on secondary structure prediction by PSIPRED 3.0 [11]. Secondary structure for the NMR structure of human
AFG3L2 IMSD, PDB ID 2LNA, is shown above the sequences.
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loop 3–4 is variable among the sequence homologs (Fig. 2F).
3.5. MD simulations of IMSD and POPC membrane
In order to elucidate the speciﬁc membrane interactions and
orientation of the IMSD relative to the mitochondrial IM, extensive
all-atom MD simulations were carried out. A lipid bilayer mem-
brane of POPC was chosen since phosphatidylcholines are the most
abundant phospholipids in the mitochondrial IM (38% overall)
[18]. All-atom simulations of peripheral protein–membrane inter-
actions have been used to determine the extent of the interactions
and are typically performed for tens to thousands of ns (several are
reviewed in [19,20]). During the MD simulation, the IMSD sponta-
neously approached and interacted with the membrane within
40 ns. We ran the MD trajectory for 200 ns, in three independent
computations, until the protein orientation with respect to the
membrane appeared to converge.
At the end of the three MD trajectories, IMSD orientations were
in agreement with our proposed membrane interaction surface
based on the surface charge distribution (Fig. 2D). The C-terminal
end of a2 was positioned furthest from the POPC membrane patch
(Gly85 immediately follows this helix) (Fig. 3A). The Trp61 side
chain was near, or embedded in, the membrane at the end of each
simulation (Fig. 3A). Lys41 in loop 2–3 was close enough to inter-
act with the phosphate moiety of the lipids at certain times in theMD simulations. Near the end of the MD trajectories, loop 3–4
(Gly57), and both N- and C-termini were within 10 Å of the mem-
brane surface, demonstrating that these regions of the IMSD can
simultaneously interact with the membrane (Fig. 3B and C). In
only the second MD run, loop 3–4 formed a helix at 50 ns and re-
mained helical for the rest of the simulation (Fig. 3C), indicating
that this loop has helical propensity when in proximity to the
membrane. The results from all three MD runs are provided in
Fig. S3.
3.6. Model for full-length AFG3L2
Since experimental characterization of the membrane interac-
tion has not been successful, our membrane interaction model of
the IMSD is based on the solution structure of the domain and
MD simulation results. Titration of the NMR sample with dodecyl
phosphocholine micelles resulted in complete unfolding of the pro-
tein and addition of POPC liposomes resulted in no change in the
1H–15N HSQC spectrum (data not shown), although disappearance
of NH peak intensities would be expected of the IMSD was in slow
exchange with the liposomes. These results further suggest that
this water-soluble domain is not likely to be half-buried in the
mitochondrial membrane.
The IMSD structure is consistent with the shape of the domain
obtained from the CET map of the Yta10/Yta12 hexaoligomer solu-
bilized in n-octyl-b-D-glucopyranoside (b-OG) detergent micelles
Fig. 2. Structure and membrane interaction surface of IMSD (A) Solution NMR structure of the human IMSD from AFG3L2 (residues 14–96), selected side chains are shown.
(B) Cartoon ﬁgure rotated from A to show the proposed membrane interaction residues. (C and D) APBS [16] solvent accessible electrostatic surface potential with same
orientation as in A and B showing negative (red), neutral (white), and positive (blue) charges. (E and F) ConSurf [17] image showing the conserved surface residues. Residue
coloring reﬂects the degree of residue conservation for selected eukaryotic homologs from Pfam06480 (42 sequences). All ﬁgures were rendered using PyMOL (DeLano
Scientiﬁc).
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TM helices resulted in the IMSDs being approximately half-buried
in the membrane (Fig. 4B). As noted by the authors, the cryo-EM
structure determined in a micelle environment may differ from
the native structure in the mitochondrial IM [1]. Indeed, since
the b-OG micelles have a radius of gyration of 30 Å [21], the mi-
celle surface surrounding the TM helices has sharp curvature com-
pared to an membrane bilayer, and this could inﬂuence the
position of IMSDs relative to the TM helices. In our new model,
the IMSDs are reorganized so that they are positioned at the sur-
face of the membrane (Fig. 4C). According to UniProt predictions
[22] of the TM helix sequences (UniProt ID Q9Y4W6), there is a
4–5 residue ‘‘spacer’’ on either side of the domain (Arg16-Tyr93)
to connect to the respective TM helices. Although the structure
of this linker is unknown, this length appears sufﬁcient to allow
the required movement of the IMSDs. Also, the IMSDs may be sit-
uated closer together as well as above the membrane in the struc-
ture of the m-AAA protease in its native membrane (not shown in
model).4. Discussion
4.1. Prohibitin interactions with IMSDs
The m-AAA proteases have many experimentally determined
protein substrates (reviewed in [2–4]). However, the only con-
ﬁrmed interaction partner for an IMSD is between the E. coli FtsH
periplasmic domain and the HﬂK and HﬂC membrane protein com-
plex (HﬂKC) [23], where HﬂK and HﬂC are related to eukaryotic
prohibitin 1 (Phb1) and prohibitin 2 (Phb2). Prohibitins have a
short hydrophobic stretch at their N-termini that anchors them
to the membrane and the remaining 30 kDa resides in the inter-
membrane space. This region of prohibitin consists of a so-called
prohibitin (PHB) and a predicted coiled-coil (CC) segment at the
C-terminal end [24]. Puriﬁed prohibitin complexes from yeast as-
sumed large 1 MDa ring-shaped structures with a diameter of
20–27 nm containing equal amounts of Phb1 and Phb2 subunits
by single particle electron microscopy [25]. The CC segment was
required for assembly of the prohibitin complex [25]. However, it
Fig. 3. (A) MD simulations of IMSD and POPC membrane. To characterize the extent of membrane insertion, the distance in the Z-dimension from the center of mass of the
lipid atoms to selected lipid or protein atoms was calculated as a function of simulation time. Select protein atoms used for the analysis were the Arg16 (atom N) and A95
(atom C) to represent the N- and C-termini, respectively, Lys41 side chain (atom NZ) to represent loop 2–3, Gly57 (atom CA) to represent loop 3–4, Trp61 side chain (atom
CZ2), and Gly85 (atom CA). Lipid atoms used were glycerol backbone (atoms C1–C3) and phosphates (atom P1). (B) and (C) Cartoon representation at 200 ns from the ﬁrst and
second MD simulation trajectories. The residues and atoms depicted in (A) are indicated as well as Asn26 and Gly85, shown with orange circles, that are predicted by PredUS
[13] to have a highly propensity for protein–protein interactions. Figures were generated using VMD software and scripts [9].
Fig. 4. Model of AFG3L2. (A) Cryo-EM structure of the yeast m-AAA protease with the human AFG3L2 shown as an orange cartoon manually ﬁt into the density. The cryo-EM
data was obtained from EMDataBank (ID 1712) [1], and PyMOL was used to generate the image. The matrix located AAA and PD domains are colored yellow, TM helices are
colored red, and IMSDs are in white. (B) The membrane, depicted as green lines, is drawn based on the location of the TM helices in the detergent micelle. (C) Model ofm-AAA
protease in a lipid bilayer. The six IMSDs are positioned above the membrane, depicted as green phospholipids. The IMSD cartoon is shown as predicted by MD simulations.
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with IMSDs.
In human mitochondria, both homo-oligomers of AFG3L2 and
hetero-oligomers of AFG3L2 and paraplegin were found in a
900 kDa protein complex by gel ﬁltration and Blue Native PAGE[26,27], signiﬁcantly larger than the 400–500 kDa expected for
m-AAA hexaoligomers. These complexes contain prohibitins as
was demonstrated in mousemitochondria [27], and in yeast, where
prohibitins were associatedwith Yta10 and Yta12 in highmolecular
weight complexes [28]. In E. coli a molecular composition of
T.A. Ramelot et al. / FEBS Letters 587 (2013) 3522–3528 3527(FtsH)6(HﬂKC)6 was proposed [29], a result that supports a 1:1
interaction with the IMSD and each pair of prohibitin proteins.
The human (AFG3L2)6(Phb1–Phb2)6 complex would be 866 kDa,
which is consistent with the experimentally determined molecular
weight of the complex. This supports a complex with 12 copies of
Phb1–Phb2 in a ring around the m-AAA protease; a structure that
seems likely based on the spread-out sixfold positioning of IMSDs
in the m-AAA hexaoligomer with a 13 nm diameter [1]. This would
ﬁt nicely inside the prohibitin central cavity of 9–16 nm [25]. It is
also consistent with our model with the IMSD protein–protein
interaction interface on the top, outside surface of the hexaoligomer
and the membrane-interaction surface at the bottom (Fig. 4). How-
ever, it remains to be experimentally determined whether the pro-
tease will be inside or outside the prohibitin ring structure [24].
Estimations of the number of copies of Phb1–Phb2 in the yeast
complex vary from 12–16 or 16–20 [25,30]; it should be noted that
the ring complexes had variability in their shape and size [25].
The role of prohibitins and their interactions m-AAA proteases
is not well understood. In yeast mitochondria, prohibitins may
act as negative regulators of m-AAA proteolysis of non-assembled
IM proteins or newly synthesized proteins because deletion of
Phb1 or Phb2 results in accelerated proteolysis by the m-AAA pro-
tease [28,30]. Prohibitins could prevent accessibility of targets to
m-AAAs by binding to the substrate or by changing the protease
activity. A direct interaction between prohibitins and newly syn-
thesized mitochondria proteins was demonstrated in yeast by co-
immunoprecipitation indicating a role of prohibitins as chaperones
that stabilize these proteins [30]. Furthermore, human Phb1 shares
sequence similarity with the bacterial chaperone GroEL, called
Hsp60 in eukaryotes [30]. It has also been suggested that prohibi-
tins may act as a scaffold to maintain the correct organization of
proteins in a lipid raft environment in order to physically separate
the substrate from the protease [24,31]. Taken together, m-AAA
proteases and prohibitins may play a role in stabilization of mem-
brane protein complexes and other chaperone-like activities [2–4].
4.2. Possible role for IMSD in substrate recognition
In general, recognition involves substrate binding to the AAA
domain, followed by ATP-dependent unfolding and translocation,
and progressive proteolysis by the PD domain. However, substrate
recognition by m-AAA proteases is not entirely understood. In
E. coli, FtsH recognized membrane proteins with 10–20 residue
unstructured N- or C-terminal ends [32]. Recognition may not
have sequence speciﬁcity but rather seems to target a broad range
of unstructured polypeptides [32]. These would include misfolded,
damaged, or non-assembled subunits. In yeast mitochondria, dele-
tion of the IMSD along with the two TM segments impaired pro-
teolysis of integral membrane proteins, indicating a possible role
for IMSDs in recognition of membrane proteins [33]. For proteins
that have residues in the intermembrane space this role could be
direct or indirect through interactions with adaptor/chaperone
proteins.
Another complexity is that substrate recognition may be differ-
ent for different targets. For example, deletion of the periplasmic
domain in E. coli resulted in FtsH that could still degrade the mem-
brane protein SecY but not the cytosolic protein CII [23]. This FtsH
mutant could no longer bind to HﬂKC, suggesting that prohibitins
can modulate interactions of some protein targets with the m-
AAA protease. In addition to prohibitins, it is likely that other spe-
ciﬁc adaptors/chaperones interact with diverse m-AAA target pro-
teins as is the case for other AAA proteases such as the prokaryotic
Clp proteases [34]. Based on our data and current understanding of
m-AAA function, we suggest that protein–protein interactions with
IMSDs will modulate degradation of a subset of protein targets.Acknowledgments
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